Search Results - "Qu, X. Melody"

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial by Palma, David A, Olson, Robert, Harrow, Stephen, Gaede, Stewart, Louie, Alexander V, Haasbeek, Cornelis, Mulroy, Liam, Lock, Michael, Rodrigues, George B, Yaremko, Brian P, Schellenberg, Devin, Ahmad, Belal, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Moore, Karen, Currie, Suzanne, Schlijper, Roel, Bauman, Glenn S, Laba, Joanna, Qu, X Melody, Warner, Andrew, Senan, Suresh

“…The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites…”
Get full text

A Primer on Interstitial Lung Disease and Thoracic Radiation by Goodman, Christopher D, Nijman, Suzan F M, Senan, Suresh, Nossent, Esther J, Ryerson, Christopher J, Dhaliwal, Inderdeep, Qu, X Melody, Laba, Joanna, Rodrigues, George B, Palma, David A

“…Interstitial lung disease (ILD) is a term used to describe a heterogeneous group of lung disorders with characteristic clinical and imaging features. Patients…”
Get more information

Optimal management of radiation pneumonitis: Findings of an international Delphi consensus study by Voruganti Maddali, Indu S., Cunningham, Cicely, McLeod, Lorraine, Bahig, Houda, Chaudhuri, Nazia, L. M. Chua, Kevin, Evison, Matthew, Faivre-Finn, Corinne, Franks, Kevin, Harden, Susan, Videtic, Gregory, Lee, Percy, Senan, Suresh, Siva, Shankar, Palma, David A., Phillips, Iain, Kruser, Jacqueline, Kruser, Timothy, Peedell, Clive, Melody Qu, X., Robinson, Clifford, Wright, Angela, Harrow, Stephen, Louie, Alexander V.

“…•We present here consensus guidelines on the diagnosis and management of radiation pneumonitis (RP).•These consensus guidelines serve as a practical guide for…”
Get full text

Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial by Palma, David A, Chen, Hanbo, Bahig, Houda, Gaede, Stewart, Harrow, Stephen, Laba, Joanna M, Qu, X Melody, Rodrigues, George B, Yaremko, Brian P, Yu, Edward, Louie, Alexander V, Dhaliwal, Inderdeep, Ryerson, Christopher J

“…Stereotactic ablative radiotherapy (SABR) has become an established treatment option for medically-inoperable early-stage (Stage I-IIA) non-small cell lung…”
Get full text

Are Female Radiation Oncologists Still Underrepresented in the Published Literature? An Analysis of Authorship Trends During the Past Decade by Zayed, Sondos, Qu, X. Melody, Warner, Andrew, Zhang, Tina Wanting, Laba, Joanna M., Rodrigues, George B., Palma, David A.

“…We examined whether female authorship, traditionally underrepresented in the radiation oncology (RO) literature, has improved during the past decade, and…”
Get full text

Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes by Harrow, Stephen, Palma, David A., Olson, Robert, Gaede, Stewart, Louie, Alexander V., Haasbeek, Cornelis, Mulroy, Liam, Lock, Michael, Rodrigues, George B., Yaremko, Brian P., Schellenberg, Devin, Ahmad, Belal, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Schlijper, Roel, Bauman, Glenn S., Laba, Joanna, Qu, X. Melody, Warner, Andrew, Senan, Suresh

“…Long-term randomized data assessing the effect of ablative therapies in patients with oligometastases are lacking. The Stereotactic Ablative Radiotherapy for…”
Get full text

Ablative Radiation Therapy to Restrain Everything Safely Treatable (ARREST): A Phase 1 Study of Stereotactic Ablative Radiation Therapy for Polymetastatic Disease by Nguyen, Timothy K., Ramadan, Sherif, Palma, David A., Corkum, Mark T., O’ Neil, Melissa, Celinski, Anders, Fakir, Hatim, Warner, Andrew, Hallock, Abhirami, Correa, Rohann J.M., Qu, X. Melody, Lock, Michael, Lang, Pencilla, Velker, Vikram, Bauman, Glenn S.

“…This phase 1 study aimed to assess the safety and feasibility of SABR therapy delivery to all sites of polymetastatic disease (>10 metastases). A 3 + 3 study…”
Get full text

What is the predictive value of RECIST criteria following stereotactic lung radiation? by Gulstene, Stephanie, Lang, Pencilla, Melody Qu, X., Laba, Joanna M., Yaremko, Brian P., Rodrigues, George B., Yu, Edward, Qiabi, Mehdi, Nayak, Rahul, Malthaner, Richard A., Fortin, Dalilah, Warner, Andrew, Inculet, Richard I., Palma, David A.

“…•During long-term follow-up, two-thirds of patients who underwent lung SABR will meet criteria for progressive disease by RECIST.•Less than 20% of these…”
Get full text

Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial by Qu, X. Melody, Chen, Yujie, Zaric, Gregory S., Senan, Suresh, Olson, Robert A., Harrow, Stephen, John-Baptiste, Ava, Gaede, Stewart, Mulroy, Liam A., Schellenberg, Devin, Senthi, Sashendra, Swaminath, Anand, Kopek, Neil, Liu, Mitchell, Warner, Andrew, Rodrigues, George B., Palma, David A., Louie, Alexander V.

“…The phase 2 randomized study SABR-COMET demonstrated that in patients with controlled primary tumors and 1 to 5 oligometastatic lesions, SABR was associated…”
Get full text

The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis by Qu, X. Melody, Velker, Vikram M., Leung, Eric, Kwon, Janice S., Elshaikh, Mohamed A., Kong, Iwa, Logie, Natalie A., Mendez, Lucas C., van der Putten, Louis J., Donovan, Elysia K., Munkarah, Adnan R., Wiebe, Ericka M., Parra-Herran, Carlos, Warner, Andrew, Louie, Alexander V., D'Souza, David P.

“…As the optimal adjuvant management of stage IA serous or clear cell endometrial cancer is controversial, a multi-institutional review was conducted with the…”
Get full text

Stereotactic Radiation Therapy in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Nonrandomized Clinical Trial by Palma, David A, Bahig, Houda, Hope, Andrew, Harrow, Stephen, Debenham, Brock J, Louie, Alexander V, Vu, Thi Trinh Thuc Toni, Filion, Edith, Bezjak, Andrea, Campeau, Marie-Pierre, Duimering, Adele, Giuliani, Meredith E, Laba, Joanna M, Lang, Pencilla, Lok, Benjamin H, Qu, X Melody, Raman, Srinivas, Rodrigues, George B, Goodman, Christopher D, Gaede, Stewart, Morisset, Julie, Warner, Andrew, Dhaliwal, Inderdeep, Ryerson, Christopher J

“…Patients with interstitial lung disease (ILD) and early-stage non-small cell lung cancer (NSCLC) have been reported to be at high risk of toxic effects after…”
Get more information

Validation of predictors for lymph node status in penile cancer: Results from a population-based cohort by Qu, X Melody, Siemens, D Robert, Louie, Alexander V, Yip, Darwin, Mahmud, Aamer

“…The ability to predict lymph node (LN) status is essential in the management of men with localized squamous cell carcinoma (SCC) of the penis. There has been…”
Get full text

129 Assessment of Precision Irradiation in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease (ASPIRE-ILD): Primary Analysis of a Phase II Trial by Palma, David, Bahig, Houda, Hope, Andrew, Harrow, Stephen, Debenham, Brock, Louie, Alexander, Vu, Toni, Filion, Edith, Bezjak, Andrea, Campeau, Marie-Pierre, Duimering, Adele, Giuiliani, Meredith, Laba, Joanna, Lok, Benjamin, Lang, Pencilla, Qu, X. Melody, Raman, Srinivas, Rodrigues, George, Goodman, Christopher, Gaede, Stewart, Morisset, Julie, Warner, Andrew, Dhaliwal, Inderdeep, Ryerson, Christopher

Get full text

Are Female Radiation Oncologists Still Underrepresented in the Published Literature? An Analysis of Authorship Trends over the Past Decade by Zayed, Sondos, MD, Qu, X. Melody, MD, Warner, Andrew, MSc, Zhang, Tina Wanting, MD, Laba, Joanna M., MD, Rodrigues, George B., MD, PhD, Palma, David A., MD, PhD

“…AbstractPurposeWe examined whether female authorship, traditionally under-represented in the radiation oncology (RO) literature, has improved over the past…”
Get full text